A cold sore from a primary herpes simplex type 1 infection can reach roughly 1 to 2 cm (about 0.4 to 0.8 inches) per blister, and clusters may join into a patch several centimeters across; lesions this large are typical of a first episode and usually peak within 3 to 5 days before crusting. Anything spreading past a few centimeters, crossing the lip onto the skin or eye, or persisting beyond about 2 weeks should be evaluated by a clinician.
Cold sores are common, but size is one of the least reliable signals of danger. A large lesion on intact skin can heal cleanly, while a small one near the eye can threaten vision. This explainer covers the biology that sets size limits, the real-world ranges clinicians see, the edge cases that change the picture, and the specific thresholds that separate wait-and-see from get-seen.
What physically caps a cold sore's size
A cold sore is the visible end of HSV-1 replicating inside skin cells at the edge of the lip, called the vermilion border. The virus enters through small breaks or mucous membrane, infects keratinocytes, and copies itself. The immune system detects this within hours and floods the area with T cells and inflammatory signals. The resulting fluid-filled vesicle is the body's containment response: fluid and cellular debris walled off by local inflammation.
The size ceiling comes from several physical and immune constraints. First, the lesion is limited to the tissue the virus can reach before adaptive immunity arrives. A healthy adult mounts a detectable T-cell response within about 24 to 72 hours of a recurrence, which is why recurrent lesions stay small and single. Second, vesicles coalesce only when viral spread outpaces local containment. Third, the lip itself is a small anatomical region, so even a large cluster is bounded by the mouth and surrounding skin.
This is why recurrences and first episodes differ so much. A primary infection hits a body with no prior HSV-1 immunity. The immune response is slower, broader, and messier. Vesicles can be larger, more numerous, and accompanied by systemic symptoms. A recurrence in someone with circulating antibodies is typically a single small blister that the immune system shuts down fast.
Plain language: the blister is a wall the body builds around infected cells, and the wall's height depends on how fast the immune system shows up.
Quantified context: how large lesions actually get
Published clinical descriptions and major dermatology references place individual cold sore vesicles at roughly 1 to 3 mm up to about 1 to 2 cm. Recurrent lesions are usually at the small end. Primary gingivostomatitis, the first-infection syndrome, produces many vesicles that can merge into larger erosions across the lips, gums, and inside of the mouth, sometimes covering several centimeters of surface area. It is the pattern, not a single giant blister, that makes primary episodes look dramatic.
Size also tracks with immune status, not with how "bad" a person's herpes is. Immunocompromised patients, including people on immunosuppressive therapy and those with advanced HIV, can develop larger, slower-healing, and atypical lesions because containment is weaker. A clinician seeing a cold sore larger than expected will ask about immune status before anything else.
The lesions are not the only measurable thing. Healing runs on a fairly consistent clock in healthy adults: tingling 12 to 24 hours before a blister appears, blister for 1 to 3 days, weeping and crusting for several days, then resolution. Total course is typically 7 to 10 days for a recurrence and up to 2 weeks for a primary episode. A lesion still growing or not crusting after two weeks is outside the usual range.
The counterintuitive detail: size and contagiousness are not in lockstep. A tiny early blister shedding virus at the tingling stage can transmit more readily than a large, dried, crusted one, because live virus is present in vesicle fluid and open erosions, not in scabs.
The timeline most cold sores follow
The table below reflects the typical course in immunocompetent adults. Timelines vary with treatment, immune status, and whether the episode is primary or recurrent.
| Stage | Typical timing | What is visible | Viral shedding |
|---|---|---|---|
| Prodrome (tingling, burning) | 12–24 hours before lesion | Nothing, or faint redness | Often already shedding |
| Vesicle | Day 1–2 | Small fluid-filled blisters, 1–3 mm to 1–2 cm | Highest shedding |
| Erosion/ulcer | Day 2–4 | Blisters rupture, weep, form shallow sores | High shedding |
| Crusting | Day 4–8 | Yellow-brown crust, sometimes cracked | Shedding declining |
| Healing | Day 8–10 | Crust lifts, new skin forms | Low shedding |
| Resolved | Day 10–14 | Faint redness or nothing | Generally none |
| Primary episode | Up to 2 weeks | Multiple vesicles, gums, inner mouth | Shedding longer |
Antiviral therapy started during the prodrome can shorten the course by roughly a day, which is why early treatment is emphasized over waiting to see how large the lesion becomes.
Size benchmarks across presentations
Different presentations have different normal ranges. Comparing them helps separate a large-but-normal cold sore from a concerning one.
| Presentation | Typical size | Usual location | Expected course |
|---|---|---|---|
| Recurrent cold sore | 1–3 mm to about 1 cm | Vermilion border of lip | 7–10 days |
| Clustered recurrence | Up to 1–2 cm total | Lip edge | 7–10 days |
| Primary gingivostomatitis | Many vesicles, merging erosions across several cm | Lips, gums, inner mouth | Up to 2 weeks |
| Herpetic whitlow | Several mm to about 1 cm | Finger | 2–3 weeks |
| Eczema herpeticum | Widespread, 1–3 mm punched-out erosions over large areas | Anywhere on eczematous skin | Requires urgent care |
| Immunocompromised lesion | Larger, atypical, slow-healing | Variable | Prolonged, often weeks |
| Ocular herpes | Small, on eyelid or cornea | Eye and surrounding skin | Needs urgent eye care |
The pattern that matters: size rises with immune naivety, immune suppression, and skin conditions that break the barrier (like eczema). A single large lesion in an otherwise healthy adult is less concerning than many small ones spreading across eczematous skin.
When size is the wrong worry signal
Patients tend to fixate on size, but clinicians watch location, spread, and host factors far more closely. A cold sore on the lip that grows to 2 cm and crusts on schedule is usually a normal primary or severe recurrence. A 3 mm lesion on the eyelid is a different problem entirely.
Red-flag warnings, where evaluation should not wait:
Eye involvement: any sore on or near the eyelid, redness of the eye, or sensitivity to light. Ocular herpes can scar the cornea and needs urgent care. Spread beyond the lip: lesions moving onto the cheek, nose, or chin in someone with eczema or broken skin, suggesting eczema herpeticum. Slow course: a lesion still growing, weeping, or unhealed after 2 weeks. Systemic illness: fever, widespread lesions, or feeling severely unwell, especially in a first episode. Immune suppression: any unusually large or atypical lesion in someone on chemotherapy, transplant drugs, or with advanced HIV. Newborn exposure: a cold sore near a baby under 3 months old is a medical emergency, because neonatal HSV can be life-threatening. This is not the baby's own lesion but exposure risk.
There is one professional caveat worth stating plainly: a clinician cannot reliably judge a cold sore from size alone, and neither can a search result. Atypical lesions, especially in older adults or immunocompromised patients, can resemble other conditions. When in doubt, the lesion gets swabbed and tested rather than eyeballed.
Misconceptions that distort the size question
Several beliefs make people either panic or underreact. The first is that a bigger cold sore means a worse infection or a stronger outbreak. Size tracks with immune naivety and containment speed more than with viral severity. A primary episode is large because the body is learning, not because the virus is more virulent.
The second is that a cold sore can spread across the whole face if touched. HSV-1 does not crawl over intact skin efficiently; it needs a portal of entry. Spread to adjacent areas is a real concern mainly when the skin barrier is broken, as in eczema, or when someone autoinoculates virus to the eye or finger by touching an active lesion.
The third is that a cold sore "turns into" a canker sore or something worse if it gets large. Cold sores and canker sores (aphthous ulcers) are different conditions: one is viral and usually on the outside of the lip, the other is not infectious and forms inside the mouth. They do not transform into each other.
The fourth is that size predicts scarring. Most cold sores heal without a scar because the infection is superficial. Deeper or repeatedly traumatized lesions, and lesions in immunocompromised people, carry more risk of pigment change or scarring.
Practical thresholds and actions
The useful question is not "how big is too big" in the abstract but "what do I do at each size and stage." These steps are general guidance, not a diagnosis, and they do not replace a clinician's assessment.
If the lesion is on the lip, small to moderate, and following the normal clock: keep it clean, avoid picking, wash hands after touching, avoid sharing utensils and towels, and avoid kissing, especially near infants. Over-the-counter topical options exist; their benefit is modest. Prescription antivirals work best when started at the tingling stage, within roughly the first 24 hours.
If the lesion is large but on the lip: the deciding factor is immune status and course, not centimeters. A 1 to 2 cm lesion in a healthy adult that crusts by day 5 and resolves by day 10 is within normal range. One that keeps expanding after day 4, or is accompanied by fever, warrants a call.
If any red flag applies: seek care the same day for eye involvement and for suspected eczema herpeticum, and promptly for slow-healing or atypical lesions. For a newborn exposed to an active cold sore, contact a clinician immediately regardless of lesion size.
Concrete thresholds to reconcile: the commonly cited 2-week mark is the outer edge of a normal course, not the point at which a lesion becomes dangerous. The 1 to 2 cm range is a typical upper bound for a single lesion in a healthy adult, not a safety line. The 3-month infant threshold is about exposure risk, not the size of anyone's sore. These numbers answer different questions and are not interchangeable.
What size cannot tell you
Size is a poor proxy for contagiousness, severity, and risk. Viral shedding peaks before a lesion is visible and during the weeping stage, when the sore may still be small. A person can transmit HSV-1 with no lesion at all through asymptomatic shedding, which is a major reason the virus is so widespread. No size measurement captures that.
Size also cannot tell you whether a lesion is HSV-1 or something else. Bacterial infections, impetigo, angular cheilitis, and aphthous ulcers can mimic cold sores, and some look larger. Only testing distinguishes them when the picture is unclear.
Finally, size does not predict how often someone will get cold sores. Recurrence frequency depends on immune history, triggers like stress, sun exposure, and illness, and individual biology, not on how big the last lesion was.
What can be concluded is narrower and more useful: in healthy adults, a cold sore of roughly 1 to 2 cm that follows the normal 7 to 10 day course is a common, self-limited event. Larger or atypical lesions, lesions near the eye, spread in eczematous skin, slow healing beyond 2 weeks, and any exposure to a newborn are the situations that change the plan. When those appear, size stops being the question and clinical evaluation becomes the answer.